|
Conc. μgmL-1 |
HCT |
ENP |
FRS |
| %Recovery |
%RSD |
%Recovery |
%RSD |
%Recovery |
%RSD |
| 2.5 |
100 |
0 |
100 |
0 |
100 |
0 |
| 5 |
100 |
0.1 |
100 |
0.1 |
100 |
0.5 |
| 10 |
101 |
0.2 |
101 |
0.4 |
101 |
0.2 |
| 15 |
11.2 |
0.01 |
11.2 |
0 |
11.2 |
0 |
| 25 |
100.02 |
0.4 |
100.02 |
0.1 |
100.02 |
0.7 |
| 50 |
100 |
0.2 |
100 |
0.6 |
100 |
0.2 |
| 100 |
101 |
0.5 |
101 |
0.2 |
101 |
0.3 |
| Assay (spiking method) |
| 80 |
100 |
0.1 |
100 |
0.1 |
100 |
0.1 |
| 100 |
100.2 |
0.2 |
100.2 |
0.2 |
100.2 |
0.1 |
| 120 |
100.3 |
0.1 |
100.3 |
0.1 |
100.3 |
0.1 |
| Assay in serum |
| 80 |
100.2 |
0.1 |
100 |
0.1 |
100 |
0.1 |
| 100 |
100 |
0.2 |
100.2 |
0.2 |
100.2 |
0.1 |
| 120 |
100.2 |
0.2 |
100.3 |
0.1 |
100.3 |
0.2 |
HCT: hydrochlorothiazide; ENP: enalapril; FRS: furosemide |